Kelonia Therapeutics
Definition
Kelonia Therapeutics is a clinical-stage biotechnology company headquartered in Boston, Massachusetts, founded in 2022, specializing in pioneering next-generation in vivo gene delivery platforms to revolutionize genetic medicines.
The company develops innovative therapies, such as MMyCAR™ and KLN-1010, aimed at generating CAR-T cells directly within patients for treating conditions like multiple myeloma, with recent milestones including FDA IND clearance in 2026 and a strategic collaboration with Johnson & Johnson.
Examples
Investors are flocking to Kelonia Therapeutics like genes to a delivery vector, betting on their in vivo magic.
Forget old-school gene therapy; Kelonia Therapeutics is the sleek Tesla of biotech, zipping right into your cells.
When Kelonia Therapeutics announced their FDA clearance, even my hypochondriac cells perked up in excitement.
Kelonia Therapeutics isn't just editing genes—they're throwing a full-on cellular rave with precision delivery.